Objectives: Frequency of venous thromboembolism in pediatric trauma patients admitted to PICUs is not insignificant, ranging up to 6%. Risk factors have been identified in this population. However, there is little consensus of actual venous thromboembolism prophylaxis practice. We examined factors associated with venous thromboembolism prophylaxis in PICUs. Design: A retrospective study evaluating associations with mechanical venous thromboembolism prophylaxis, pharmacologic venous thromboembolism prophylaxis, or dual therapy (DUAL) prophylaxis compared with no venous thromboembolism prophylaxis. Multivariable logistic regression explored the relationship between prophylaxis type and selected covariates with stepwise selection method to identify the independent predictors of venous thromboembolism prophylaxis utilization. Setting: Five level I/II pediatric trauma centers in the United States. Patients: Children less than 18 years from January 1, 2013, to December 31, 2013, admitted to the PICU after a trauma, identified through combined trauma registry and Virtual Pediatric Systems database.
H ospital-acquired venous thromboembolism (VTE) in pediatrics is a major source of comorbidity causing increased length of stay (LOS) and costs in excess of $27,000 per VTE (1) . The frequency of VTE in children remains lower than adults, but is increasingly diagnosed in hospitalized pediatric patients, presumably from improvements in the care of critically ill children, increased awareness, and better detection methods (2) . With the increased incidence of VTE in hospitalized children, quality improvement initiatives have been set in place to prioritize VTE prevention as a national concern (3).
The incidence of VTE in injured children is higher than in the general hospitalized pediatric population, ranging from 0.02% to 1% for children hospitalized after trauma (2, (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) , and as high as 3-6% in critically ill injured children (6, 9, 14) . Risk factors associated with VTE in pediatric trauma patients have been identified and include older age, higher Injury Severity Scores (ISS), major vascular injury, central venous catheter use, poor perfusion, inotropic support, immobility, and spinal cord injury (5, 8, (12) (13) (14) (15) (16) . Despite the growing awareness of the risk for VTE in critically injured children, VTE prophylaxis in critically ill children is uncommonly and inconsistently used, even in high-risk populations (17) . In part, this is likely because there remains insufficient evidence to guide providers in the use of VTE prophylaxis. Recently published consensus guidelines for VTE prophylaxis after pediatric trauma were reliant on the Delphi method in light of the paucity of data (18) .
The purpose of our study was to identify factors associated with mechanical VTE prophylaxis (MPx) or pharmacologic VTE prophylaxis (PPx) in pediatric trauma patients admitted to the PICU to better understand current VTE prophylaxis utilization patterns.
MATERIALS AND METHODS
This was a retrospective, multicenter analysis of the existing deidentified Pediatric Trauma Assessment and Management (PTAM) database. The PTAM database was created by merging institutional trauma registry (TR) and PICU data from Virtual Pediatric Systems (VPS), LLC (Los Angeles, CA) at five pediatric trauma centers (PTCs). All children meeting the following eligibility criteria were included: discharged from the PICU during calendar year 2013, less than 18 years old at the time of discharge, and at least one documented International Classification of Diseases, 9th Edition, Clinical Modification (ICD-9-CM), code 800-959.9, indicating a traumatic injury, and indication of traumatic injury in the VPS participant profile. The requested dataset had institutional review board approval from the sponsoring institutions, and all data were deidentified from the patient and hospital. All five contributing sites were PTCs verified by either the American College of Surgeons and/or certified by the state, with four of the sites being level I and one site being level II.
Variables Collected
Factors hypothesized to be associated with initiation and choice of VTE prophylaxis were analyzed including patient demographics, time of initiation of any PPx or MPx, PICU admit date, PICU discharge date, hospital discharge date, hospital disposition, PICU LOS, emergency department (ED) Glasgow Coma Scale (GCS), ISS, Pediatric Risk of Mortality (PRISM) 3 score, Pediatric Logistic Organ Dysfunction score, and Pediatric Index of Mortality (PIM) 2 score upon PICU admission, mechanisms of injury, and ICD-9-CM diagnosis and procedure codes to evaluate injuries, interventions, and comorbidities. The main outcome of this study was to determine the factors associated with the use of MPx or PPx within 48 hours of PICU admission. Forty-eight hours was chosen to capture early intervention efforts to mitigate development of VTE, as VTE risk is known to increase shortly after traumatic injury (14) . Secondary outcomes included complications, LOS, change in functional status from preinjury to that at ICU discharge, and mortality.
Study Definitions
MPx was defined as the use of sequential compression devices or any other form of intermittent pneumatic compression applied during the PICU stay to prevent VTE. PPx was defined as the use of medications including heparin, low molecular weight heparin, direct thrombin inhibitor, oral Xa inhibitor, or warfarin with the intention to prevent VTE. If both MPx and PPx were used, we defined it as "DUAL" therapy. When combining any form of prophylaxis (MPx, PPx or DUAL therapy), we used the terminology "ANY Px" to indicate use of one or both prophylactic therapies.
Patient characteristics included age, gender, body mass index (BMI), and comorbidities existing prior to injury. Comorbidities captured in the TR database included ascites, bleeding disorder, active chemotherapy, cancer, congenital heart disease, congestive heart failure, smoking status, chronic renal failure, acute kidney injury, history of cerebrovascular accident, diabetes mellitus, previous history of VTE, varices, hypertension, prematurity, obesity, steroid use, cirrhosis, psychiatric disorder, and drug dependence. BMI was calculated by height and weight data collected at PICU admission through VPS and defined as weight (kg)/(height [m]) 2 . Obesity and BMI were classified independently to optimize capture of these important covariates. A binary comorbidity variable was created for obesity and analyzed as an aggregate (yes/no) and for number of comorbidities.
ED disposition was classified as either direct admission to the PICU or operating room procedure then admission to the PICU. The highest reported GCS was from the first 24 hours of hospital arrival and was collected by the TR via the Trauma Quality Improvement Program guidelines (19) . ED GCS was the first GCS recorded upon ED/hospital arrival. Injury severity was characterized by mechanism of injury, ISS, and ED GCS. Mechanism of injury was defined by ICD-9-CM primary external cause of injury codes (E-codes) and grouped into the following categories: motor vehicle collision, falls, struck by/ against, burns, cut/pierce (stab injury), firearm, bites/stings, and all other injury. Injury severity was characterized by mechanism of injury, ISS, and ED GCS ( Table 1) .
Procedure diagnoses were determined from the primary ICD-9-CM procedure codes and grouped into categories: brain/spinal cord (01-03), cardiac/blood vessel (35-39), abdomen (42-54), respiratory (30-34), musculoskeletal (76-84), and any operative procedure (00-86). Similarly, injury diagnosis codes were determined from the primary ICD-9-CM diagnosis code and grouped into categories based on anatomic and physiologic injury patterns: intracranial head injury (850-854), thoracic injury (860-862), abdominal/pelvic injury (863-869), burn injury (940-949), blood vessel injury (900-904), lower extremity fracture (820-823, Other outcomes for the study including LOS, change in Pediatric Overall Performance Category (POPC) from discharge to admission baseline, change in Pediatric Cerebral Performance Category (PCPC) from discharge to admission baseline, and mortality. The VTE prophylaxis versus no prophylaxis groups were analyzed using generalized linear models (assuming gamma/negative binomial distribution with log link) for the outcome LOS, delta POPC/ PCPC and using logistic model for mortality, and were adjusted for ISS. An unadjusted p value of 0.05 was used for significance. Software used was SAS Version 9.4 (SAS Institute, Cary, NC).
RESULTS
A total of 692 patients were included in the database, with 55 excluded from analysis due to missing data. Demographic and injury characteristics of the cohort are shown in Table 1 . Of the included 637 patients, 538 (84.5%) had no VTE prophylaxis by 48 hours, 11 (1.7%) had both PPx and MPx (DUAL), 77 (12.1%) had only MPx, and 11 (1.7%) had PPx alone. Increasing age was associated with all forms of VTE prophylaxis (DUAL, MPx, PPx) with the 13-17 years age group associated with DUAL and MPx. The median age of those receiving any form of prophylaxis was higher (14.0 yr) than for those who did not receive any form of prophylaxis (4 yr). Patients receiving any prophylaxis versus none had similar demographics and injury characteristics. Higher age, BMI, and ISS were associated with prophylaxis use (Table 1) . The relative associations between chosen variables and VTE prophylaxis are presented in Table 2 . In univariate analysis, diagnosis of lower extremity long bone fractures was associated with higher utilization of dual prophylaxis use (odds ratio [OR], 11.3; 95% CI, 3.3-38.8). Orthopedic procedures were associated with higher utilization of DUAL prophylaxis use (OR, 9.2; 95% CI, 2.7-31.1), PPx (OR, 13.4; 95% CI, 3.8-47.2), and MPx (OR, 3.3; 95%CI, 1.9-5.7). Brain/spinal cord procedures (OR, 2.5; 95% CI, 1.4-4.2) were associated with MPx. Procedures for head trauma and diagnosis of head injury were associated with a decreased use of all prophylaxis types. Abdominal procedures were associated with DUAL and MPx, but not PPx. Admission to ICU postoperatively was associated with a higher rate of all forms of prophylaxis (DUAL, MPx, PPx, and ANY Px). There was no significant association between study sites with MPx alone (11.7% overall; range, 0-19.1; p = 0.31), although site was associated with PPx prophylaxis (6.3% overall; range, 0-20.2; p < 0.0001).
In multivariable analyses, older age and orthopedic procedures were associated with all methods of VTE prophylaxis ( Table 3 ). Higher BMI, although significant in univariate analysis, was not associated with prophylaxis of any type after controlling for covariates. Brain/spinal cord procedures and abdominal procedures were associated with MPx, but not PPx, whereas cardiac/vascular procedures were associated with PPx. There was no significant association between injury diagnoses without the corresponding procedure, aside from head injury, which was inversely associated with ANY Px. Patient comorbidities were inversely associated with MPx.
In the outcomes analysis, patients who received any form of prophylaxis had longer physical and hospital LOS and worsening change in POPC, even while controlling for ISS. There was no difference in mortality ( Table 4) .
DISCUSSION
This is a multi-institutional study describing actual thromboprophylaxis practices being implemented in the PICU setting for pediatric trauma patients. Previous studies have identified the incidence and risk factors for VTE in critically injured children (6, 9, 14), but it is not known how providers are interpreting those data and implementing VTE prophylaxis in their management of pediatric trauma patients. We investigated the actual clinical practices being implemented in the PICU setting. This is the first multicenter report describing actual VTE prophylaxis practices in the critically ill pediatric trauma population across centers.
The results of our univariate analysis showed that risk factors for VTE such as older patient age, increased BMI, neurosurgical, spine, abdominal, orthopedic, or vascular procedures, in addition to lower extremity long bone fractures and admission to the PICU postoperatively, were associated with VTE prophylaxis in this patient population. Head injured patients were less likely to receive prophylaxis of any type. Interestingly, older age and orthopedic procedures were the only factors associated with all forms of VTE prophylaxis in multivariate analyses. Age has been reported in several studies as a risk factor for VTE in the pediatric population (4, 7, 15, 20) , and our study may imply that providers appropriately assess age as a strong risk factor for VTE.
Reporting actual VTE practices in the pediatric population is relevant to the clinician. The incidence of VTE in PICUs has dramatically increased, but guidance for how to incorporate this evidence is lacking (21, 22) . The thromboprophylaxis practices observed in this study, with little prophylaxis use in those less than 12 years and decreased PPx and DUAL in patients with head injury, are consistent with a recent consensus statement on VTE prophylaxis in pediatric trauma patients, which states that most patients 12 years old and younger do not need prophylaxis and that MPx has a role in patients who cannot safely receive PPx, such as in head trauma patients with risk of bleeding (18) . The practices we observed, however, are inconsistent with the recommendations from the Pediatric Trauma Society (PTS) and the Eastern Association for the Surgery of Trauma (EAST) to use PPx in spinal cord injuries, obesity and vascular injuries in pediatric trauma patients (21, 23) . However consistent with these recommendations, our study showed an increased ISS in patients receiving DUAL, but not MPx, PPx, or ANY Px prophylactic therapy, compared with those who received none. We also found that, among these high-level PTCs, site variation exists for PPx but is fairly uniform for MPx. This is similar to the findings of the Protract (Prophylaxis Against Thrombosis Practice) Study, which identified site variation among global institutional participants; however, they found variation for both MPx and PPx utilization in critically ill children (17) . The authors theorized that the high variability in practice was related to the lack of evidence to guide practitioners.
In our study, some high-risk populations were not associated with receiving VTE prophylaxis. As this was an observational study, the intent of providers could not be determined. For example, in these situations, it is unclear whether VTE prophylaxis was not given because of a lack of recognition of VTE risk or due to an assessment of an increased risk of bleeding that is not evident in the data available. This variability may indicate that institutions need to implement a formal screening tool to guide providers on appropriate patients in which to use VTE prophylaxis. Connelly et al (11) recently developed an internally validated VTE screening tool from the National Trauma Database for pediatric trauma patients. A screening tool such as this implemented on a larger scale may help providers in identifying high-risk populations and guide their decision on VTE prophylaxis. This study has also identified patient factors associated with the decision to use prophylaxis. This is important information as we move to the next phase of studies in this area, beyond epidemiology and on to outcomes and effectiveness. Knowing physicians are comfortable with PPx in older children, those with orthopedic or vascular procedures will allow us to form cohorts from which to compare outcomes or design randomized controlled trials.
LIMITATIONS
There are some limitations to this retrospective study. We only looked at thromboprophylaxis in the first 48 hours after admission. The 2016 PTS consensus guidelines endorse waiting 3-4 days for PPx following neurosurgical procedures, intracranial hemorrhage, and major solid organ injury (18) ; hence, we may have missed a small population of patients who had prophylaxis appropriately initiated after 48 hours. Review of our data shows that six patients had some form of VTE prophylaxis started after 48 hours and all of them had a diagnosis of intracranial head injury or a brain/spinal cord procedure. The 2013 data in this study may not reflect recent practice changes since the 2016 PTS and EAST guidelines; however, there is often a significant lag between guideline release and clinical practice implementation (24, 25) .
As with any established multicenter database, there are inherent questions of accuracy related to the data captured. Although the five trauma centers included in this study have broad geographic distribution, generalizability of this study is limited by the sample size.
CONCLUSIONS
PPx is not common in critically ill children after trauma. Patient age, orthopedic and vascular procedures, and increased injury severity are associated with PPx. Higher BMI and other comorbidities are not associated with the increased use of VTE prophylaxis.
